NeurOp
Manufacturing · Georgia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
58 Edgewood Ave NE Ste 122, Atlanta, Geo...Phone Number
(404) 941-2350Website
www.neuropinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NeurOp
NeurOp, Inc. is a clinical-stage biotechnology company focused on developing medicines for central nervous system (CNS) disorders, including pain, stroke, subarachnoid hemorrhage, and treatment-resistant depression. The company specializes in targeting various subunits of N-methyl-D-aspartate (NMDA) receptors to create promising drug compounds. NeurOp aims to address significant medical needs through its innovative therapies. Their intended clients include patients suffering from CNS disorders and healthcare providers seeking effective treatment options.Explore more
NeurOp Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeurOp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NeurOp launches new products
Check if NeurOp has recently received funding, and reach out quickly before it becomes old news!
NeurOp, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NeurOp
Click to see if NeurOp had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NeurOp recently announced quarterly report
Check out if NeurOp is spiking on competitors!
Funding: Get notified immidiatlly once NeurOp has new funding data
Recommended Actions
Reach out to Masked Content who joined NeurOp as Masked Content
Find more new buyers
Compare Similar Companies to NeurOp
Compare insights from companies similar to NeurOp, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeurOp is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeurOp is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeurOp.
NeurOp Tech Stack
A closer look at the technologies used by NeurOp
NeurOp News & Media
NeurOp Receives FDA Orphan Drug Designation for NP10679 for Treatment of Subarachnoid Hemorrhage
ATLANTA--(BUSINESS WIRE)-- #CNS--NeurOp, Inc. has received FDA orphan drug designation for its lead clinical candidate NP10679 for the treatment of subarachnoid hemorrhage (SAH).NeurOp Initiates Phase 1 Clinical Trial of NMDA Receptor Inhibitor NP10679
ATLANTA, GA / ACCESSWIRE / April 12, 2018 / NeurOp, Inc., a clinical-stage biotechnology company, today announced the initiation of a Phase 1 clinical trial of NP10679, a highly potent and selective GluN2B subunit-specific NMDA (N-methyl-D-aspartate) receptor inhibitor. NeurOp is investigating NP10679 for several neurological disorders that are associated with over-activity of these receptors. The randomized, placebo-controlled, single ascending dose study will assess the safety, pharmacokinetic
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeurOp
Sign Up For FreeTo access detailed company insights
NeurOp, Inc. is a clinical-stage biotechnology company focused on developing medicines for central nervous system (CNS) disorders, including pain, stroke, subarachnoid hemorrhage, and treatment-resistant depression. The company specializes in targeting various subunits of N-methyl-D-aspartate (NMDA) receptors to create promising drug compounds. Neu... Read More
